Status:
COMPLETED
MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
Lead Sponsor:
City of Hope Medical Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
MicroRNAs (MiRNAs) regulate the translation of RNAs and are implicated in cell proliferation and renewal both under physiologically normal as well as in malignant conditions. Dysregulation of specific...
Detailed Description
Current neoadjuvant or adjuvant treatment strategies do not allow for rationale incorporation of such agents. One needs tools to predict both de novo and acquired resistance to therapeutic agents. Thi...
Eligibility Criteria
Inclusion
- Female,
- Breast Cancer
- \> 18 years,
- regardless of histology, treatment phase, or stage
Exclusion
- \-
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 20 2019
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT01231386
Start Date
November 1 2009
End Date
May 20 2019
Last Update
June 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope
Duarte, California, United States, 91010